Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-25-005246
Filing Date
2025-12-10
Accepted
2025-12-10 16:30:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9993
  Complete submission text file 0000902664-25-005246.txt   11689
Mailing Address WHITELEY CHAMBERS DON STREET ST. HELIER Y9 JE2 4TR
Business Address WHITELEY CHAMBERS DON STREET ST. HELIER Y9 JE2 4TR (212) 729-7524
Darwin Global Management, Ltd. (Filed by) CIK: 0001839209 (see all company filings)

EIN.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Subject) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93970 | Film No.: 251562361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)